|
"he yh"的相關文件
顯示項目 1-5 / 5 (共1頁)
1
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2024-06-17 |
Plain language summary of the FOENIX-CCA2 study: Futibatinib for people with advanced bile duct cancer
|
Goyal, L; Meric-Bernstam, F; Hollebecque, A; Valle, JW; Morizane, C; Karasic, TB; Abrams, TA; Furuse, J; Kelley, RK; Cassier, PA; Klümpen, HJ; Chang, HM; Chen, LT; Tabernero, J; Oh, D; Mahipal, A; Moehler, M; Komatsu, Y; Ahn, DH; Epstein, RS; Halim, AB; Wacheck, V; He, YH; Liu, M; Benhadji, KA; Bridgewater, JA |
| 國家衛生研究院 |
2021-07 |
Primary results of phase 2 FOENIX-CCA2: The irreversible FGFR1-4 inhibitor futibatinib in intrahepatic cholangiocarcinoma (iCCA) with FGFR2 fusions/rearrangements
|
Goyal, L;Meric-Bernstam, F;Hollebecque, A;Morizane, C;Valle, JW;Karasic, TB;Abrams, TA;Kelley, RK;Cassier, P;Furuse, J;Klumpen, HJ;Chang, HM;Chen, LT;Komatsu, Y;Masuda, K;Ahn, D;He, YH;Soni, N;Benhadji, KA;Bridgewater, JA |
| 中山醫學大學 |
2021 |
ER alpha determines the chemo-resistant function of mutant p53 involving the switch between lincRNA-p21 and DDB2 expressions
|
He, YH; Yeh, MH; Chen, HF; Wang, TS; Wong, RH; Wei, YL; Huynh, TK; Hu, DW; Cheng, FJ; Chen, JY; Hu, SW; Huang, CC; Chen, Y; Yu, JX; Cheng, WC; Shen, PC; Liu, LC; Huang, CH; Chang, YJ; Huang, WC |
| 國家衛生研究院 |
2012-07 |
Genetic variation in the carbonyl reductase 3 gene confers risk of type 2 diabetes and insulin resistance: a potential regulator of adipogenesis
|
Chang, YC;Liu, PH;Tsai, YC;Chiu, YF;Shih, SR;Ho, LT;Lee, WJ;Lu, CH;Quertermous, T;Curb, JD;Lee, PC;He, YH;Yeh, JI;Hwang, JJ;Tsai, SH;Chuang, LM |
| 國家衛生研究院 |
2012-05 |
Genetic variation in the carbonyl reductase 3 gene confers risk of type 2 diabetes and insulin resistance: a potential regulator of adipogenesis [Erratum: Journal of Molecular Medicine. 2012 Jul;90(7):847-858.]
|
Chang, YC;Liu, PH;Tsai, YC;Chiu, YF;Shih, SR;Ho, LT;Lee, WJ;Lu, CH;Quertermous, T;Curb, JD;Lee, PC;He, YH;Yeh, JI;Hwang, JJ;Tsai, SH;Chuang, LM |
顯示項目 1-5 / 5 (共1頁)
1
每頁顯示[10|25|50]項目
|
